Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control

J Inherit Metab Dis. 2008 Dec;31(6):729-32. doi: 10.1007/s10545-008-0919-5. Epub 2008 Aug 19.

Abstract

While the presence of hyperlipidaemia in glycogen storage disease (GSD) type Ia and Ib is generally accepted, few investigators have adequately assessed lipid profiles of GSD III in children, in whom the presence of hyperlipidaemia may be most prominent. We analysed the lipid profiles in 44 GSD III patients from 6 months to 30 years of age. Hypertriglyceridaemia and hypercholesterolaemia were common in children younger than 3 years of age. Hypertriglyceridaemia correlated negatively with age, and may reflect increased severity of hypoglycaemia in this younger population. The presence of hyperlipidaemia during childhood in these patients identifies another GSD population that could be at risk for early cardiovascular disease (CVD). Consequently, the outcome of clinical trials investigating the vascular effect of hyperlipidaemia in GSD applies to types other than GSD I.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Biopsy
  • Child
  • Child, Preschool
  • Glycogen Storage Disease Type III / complications
  • Glycogen Storage Disease Type III / diagnosis*
  • Glycogen Storage Disease Type III / therapy
  • Humans
  • Hyperlipidemias / complications
  • Hyperlipidemias / diagnosis*
  • Hyperlipidemias / therapy
  • Infant
  • Infant, Newborn
  • Risk Factors